24
Feb
2021
17:00
GMT
Webinar
Improving Atrial Fibrillation Treatment Outcomes With First Line Cryoablation
-
Views:
5030
-
Likes:
22
Overview
The objective of this session is to discuss the significance of the 2020 ESC guidelines on atrial fibrillation (AF) and new evidence demonstrating the benefits of early rhythm control and first-line cryoablation. This online session will feature results from the EAST, CRYO-FIRST and STOP AF First, and EARLY AF trials.
To provide background information and maximise the learning potential of this session, we recommend attendees refer to the following videos in advance of the broadcast:
A summary of the EARLY-AF, STOP AF First, and CRYO-FIRST clinical trials
Highlights from the 2020 ESC guidelines on AF management
Attendees will be able to submit questions for the faculty in advance and throughout the broadcast.
Faculty:
Carina Blomström-Lundqvist
Jason G Andrade
Yassir Javaid
Magnus Forsgren
Paulus Kirchhof
This webinar is supported by
Agenda
Target Audience
- This educational session primarily targets general cardiologists and primary care physicians.
Learning Objectives
- AF progression and the importance of early treatment (e.g. EAST - AFNET trial)
- Key updates to the ESC guidelines on AF management
- New evidence on first line cryoablation: CRYO-FIRST, STOP AF First, and EARLY AF trials
- Optimising the treatment pathway and improving the standard of care for AF patients
Faculty Biographies
Carina Blomström-Lundqvist
Dr Carina Blomström-Lundqvist is Professor of Cardiology at the Department of Cardiology, Institution of Medical Science, Uppsala, SE and Senior Consultant and Professor at the Department of Cardiology and Medical Science, Örebro University Hospital, Örebro, SE.
Jason G Andrade
Dr Jason Andrade is a Cardiac Electrophysiologist at Vancouver General Hospital in Canada, with joint appointment at St Paul’s Hospital and the Montreal Heart Institute.
Yassir Javaid
Dr Yassir Javaid, Cardiovascular & Diabetes Lead Northamptonshire CCG, UK. Qualified from Cambridge University and completed his GP VTS training in Northampton.
Magnus Forsgren
Dr Magnus Forsgren, Head Physician, Cardiology Clinic, Falun Hospital, Sweden
Paulus Kirchhof
Prof Kirchhof is the Director of the Institute of Cardiovascular Sciences at the University of Birmingham.
Key References
1. Andrade, J. et al., 2020. Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation. New England Journal of Medecine
2. Wazni et al., 2020. Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation. New England Journal of Medecine
3. Hindricks, G. et al., 2020. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). European Heart Journal. 00, 1-126
4. Kuniss et al. Presented at the German Cardiac Society conference DGK 2020
5. Chierchia, GB. et al., 2020. Quality of Life Measured in First-Line Therapy During the CRYO-FIRST Study: A Comparison Between Cryoballoon Catheter Ablation Versus Antiarrhythmic Drug Therapy. Poster presented at the 2020 ESC Congress – The Digital Experience
6. Hermida et al., 2020. Cryoballoon catheter ablation versus antiarrhythmic drugs as a first-line therapy for patients with paroxysmal atrial fibrillation: Rationale and design of the international Cryo-FIRST study. Am Heart J. 222:64-72